Pangea Biomed Receives $5 Million in Seed Round Financing
Pangea Biomed is a cancer treatment technology service provider that aims to bring effective precision oncology to cancer patients, improve oncology drug development, and enable oncologists to successfully treat patients. Recently, Pangea Biomed announced that it has received an additional investment of $5 million, led by angel investor Danny Tocatly and existing investor NFX, which […]
Pangea Biomed Receives $5 Million in Seed Round Financing Read More »